HAV VP1, Hepatitis A Virus Antigen, Recombinant
| Full Name |
HAV VP1, Hepatitis A Virus Antigen, Recombinant
|
Abbreviated Name-1 |
HAV-VP1; Hepatitis A Virus-VP1; |
| Documents |
|---|
| Figures |
|---|
| Reference |
|---|
Haro I, et al. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. FEBS Lett. Apr 2003; 540(1-3): 133-140.
Costa-Mattioli M, et al. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J. Virol. Sep 2002; 76(18): 9516-9525.
Graff J, et al. Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J. Virol. Jul 1999; 73(7): 6015-6023.
|
|
Description |
Hepatitis A Virus (HAV) VP1 is an E. coli-derived recombinant. The protein Hepatitis A Virus (HAV) VP1 contains the HAV VP1 immunodominant regions, amino acids: 524-633. |
Source |
E. coli |
M.W. |
33,000 Da |
Purity |
Protein is >90% pure as determined by 10% PAGE (coomassie staining). |
Storage |
Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
Concentration |
1 mg/ml in 10 mM CBB, pH 9.6, 0.1% SDS, 50% glycerol |
Stability |
Five years frozen. one month in solution at room temperature. |
Specificity |
Immunoreactive with sera of HAV-infected individuals |
Applications |
Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems |
Note |
; |
Related Products
 |
1 |
Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 . |
2 |
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins. |
3 |
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems. |
4 |
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells. |
5 |
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level. |
|
